Search

everythinglearnresearchcommunity

for

Search:↓

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Taking finasteride before surgery reduces blood loss in prostate procedures.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Kolaviron and quercetin may help treat prostate issues.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Thermobalancing Therapy can treat enlarged prostate and improve men's quality of life.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The normal human prostate does not significantly affect blood DHT levels.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Dutasteride may help shrink prostate cancer tumors.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Finasteride reduces bleeding during prostate surgery.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Dutasteride is more cost-effective than finasteride for treating benign prostatic hyperplasia in Montenegro.

Flutamide rarely causes liver toxicity in prostate cancer patients.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Vertex pattern hair loss linked to higher prostate cancer risk.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Certain genetic markers on the Y-chromosome may influence prostate cancer risk in Iraqi males.

Vitamin D may help regulate cholesterol and influence prostate cancer development.